Delaware BioScience Association Announces Comprehensive Policy Agenda for Growth of State Life…

The Delaware BioScience Association today announced a comprehensive series of policy recommendations to accelerate the growth of the state’s thriving life science industry and improve public health.

Developed in partnership with member businesses and academic research institutions, economic development organizations, government and elected officials and extensive assessment of best-practices from across the country, the Delaware Bio policy roadmap focuses on four key areas:

• Sparking and attracting life science innovation and investment
• Transforming our STEM workforce
• Enhancing and integrating state economic & workforce development efforts
• Expanding patient access to innovation and reducing costs

“These initiatives align perfectly with priorities articulated by Governor Meyer and the General Assembly including investing in STEM education and community quality of life, expanding economic opportunities for all and ensuring access to affordable, state-of-the-art healthcare,” said Michael Fleming, Delaware Bio President and CEO.

“We look forward to working with Governor Meyer and legislators to advance these smart, common-sense proposals to drive continued life science innovation and investment -- a source of unrivaled economic value and future opportunity for our state and most importantly, a transformational impact on public health and countless individual lives.”

Delaware’s bustling life science ecosystem includes pharmaceutical and biotechnology firms, instrumentation, medical device and diagnostic companies, research, development and manufacturing firms, agricultural biotech, hospital and academic research institutes, and an array of essential business service providers. The sector’s significant recent growth has been fueled by new company formation, strategic investments in key sites and facilities, and the expansion of major global employers. Today, the sector directly supports more than 12,000 jobs across research and development, manufacturing, medical devices, biotechnology, and pharmaceutical production, with thousands more high-value jobs in construction, industrial services, law, accounting, consulting and other fields critical to the industry’s success.

“Unique among industries, the research, development and successful manufacturing of life science products and technologies requires immense time, study and investment over many years,” said Fleming. “To ensure our continued growth – and enhance Delaware’s posture in a competitive regional and indeed international market – it is essential the state advance a strategy focused on supporting the dedicated Delaware scientists who devote their lives to bringing biomedical innovation to patients in need.”

To download “Accelerating Delaware’s Life Science Leadership” click here.